| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2724597 | The American Journal of Medicine | 2009 | 4 Pages |
Abstract
Evidence-based management of chronic systolic heart failure includes risk factor management, therapeutic lifestyle changes, and a polypharmaceutical regimen that prolongs survival, reduces or reverses progression of myocardial dysfunction, alleviates symptoms, and limits complications. Subspecialty consultation is warranted when symptoms progress despite standard therapy; interventions are needed for refractory coronary disease, an arrhythmia device is indicated, or surgical intervention or transplantation is considered.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Stephen A. Geraci, Jessie M. Spencer, Nancy D. Stubbs,